| Pharmaceutical active ingredients: |
| Mesalamine |
| Available forms, composition and doses of Lialda: |
| Tablets, Delayed Release; Oral; Mesalamine 1.2 g |
| Lialda medical category: |
| Human:Anti-inflammatory agentsGIT regulators, antiflatulents and anti-inflammatories |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A07EC02 - Mesalazine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| ShireCosmo PharmaceuticalsGiuliani |
| Related documents and information about Lialda: |
| Lialda prescribing information (PDF) |